#ASCO19, Twitter, 6/10/2019 11:38:31 PM, 199640


FAQ | Problem?

#ASCO19_2019-06-10_13-14-04.xlsx
#ASCO19_2019-06-10_13-14-04.xlsx
From:
Connected Action NodeXL-Reports
Uploaded on:
June 10, 2019
Short Description:
#ASCO19 via NodeXL http://bit.ly/2WYPtea
@asco
@ci4cc
@katsuakimaehara
@cleclinicmd
@nejm
@marklewismd
@narjustdumamd
@cityofhope
@tmprowell
@institut_curie

Top hashtags:
#asco19
#cancer
#lcsm
#bcsm
#breastcancer
#oncoalert
#oncology
#lymsm
#asco2019
#immunotherapy

Description:
Description
The graph represents a network of 7,970 Twitter users whose recent tweets contained "#ASCO19", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Monday, 10 June 2019 at 20:43 UTC.

The tweets in the network were tweeted over the 7-day, 0-hour, 45-minute period from Monday, 03 June 2019 at 19:27 UTC to Monday, 10 June 2019 at 20:13 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 7970
Unique Edges : 19751
Edges With Duplicates : 14079
Total Edges : 33830
Self-Loops : 3221
Reciprocated Vertex Pair Ratio : 0.0565976110488988
Reciprocated Edge Ratio : 0.107131817178185
Connected Components : 299
Single-Vertex Connected Components : 171
Maximum Vertices in a Connected Component : 7366
Maximum Edges in a Connected Component : 33056
Maximum Geodesic Distance (Diameter) : 16
Average Geodesic Distance : 4.049471
Graph Density : 0.000356541573503222
Modularity : 0.392582
NodeXL Version : 1.0.1.413

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[55] https://www.symplur.com/entropy/dramatic-growth-in-doctor-engagement-at-asco-2019/
[43] http://abstracts.asco.org/239/index.html
[26] https://twitter.com/symplur/status/1136419790250078208
[25] https://www.nejm.org/doi/full/10.1056/NEJMoa1903765
[22] https://twitter.com/ASCO/status/1135969545548652545
[21] https://elpais.com/elpais/2019/06/06/ciencia/1559836593_115131.html
[21] https://seom.org/formacion/formacion-on-line/onconexion-2019
[18] https://ascopubs.org/doi/full/10.1200/EDBK_100019
[17] https://myriadmyrisk.com/
[15] https://www.sciencesetavenir.fr/sante/cancer/asco-2019-des-nanoparticules-testees-dans-les-cancers-orl_134164?utm_medium=Social&utm_source=Twitter#Echobox=1559667159

Top URLs in Tweet in G1:
[43] https://www.symplur.com/entropy/dramatic-growth-in-doctor-engagement-at-asco-2019/
[24] https://twitter.com/symplur/status/1136419790250078208
[13] https://twitter.com/ASCO/status/1135969545548652545
[10] https://ascopubs.org/doi/full/10.1200/EDBK_100019
[9] https://www.vjhemonc.com/video/u0zx1xnqm4-treating-high-risk-myeloma-in-the-elderly/
[8] https://twitter.com/symplur/status/1137118820798091265
[7] https://www.ascopost.com/videos/2019-asco-annual-meeting/patricia-ganz-on-breast-cancer-whole-vs-partial-breast-irradiation/
[6] https://twitter.com/mm_hub/status/1135923703961833473
[6] https://www.onclive.com/conference-coverage/asco-2019/amg-510-active-in-kras-nsclc
[6] https://www.cancernetwork.com/article/dr-pennell-guidelines-barriers-and-access-molecular-testing-nsclc

Top URLs in Tweet in G2:
[14] https://www.nejm.org/doi/full/10.1056/NEJMoa1903835?query=featured_home
[13] https://www.anzup.org.au/docview.aspx?id=991
[7] https://www.vjoncology.com/video/yedcgr8fhk4-immune-checkpoint-inhibitors-for-urothelial-cancer/
[6] https://www.symplur.com/entropy/dramatic-growth-in-doctor-engagement-at-asco-2019/
[6] https://www.vjoncology.com/video/ogzw1bk-trq-pushing-the-boundaries-in-prostate-cancer-imaging/
[5] https://www.medscape.com/viewarticle/913861?src=soc_tw_190604_mscpedt_news_onc_surgery&faf=1
[4] https://www.oncologytube.com/video/if-they-are-imaging-negative-how-are-they-responding-no-imaging-modality-is-perfect-80-25-use-plain-imaging-which-is-not-as-sensitive-as-what-were-doing-now/10006512
[4] https://www.oncologytube.com/video/the-broad-implications-of-the-sual-study/10006473
[4] https://www.oncologytube.com/video/photoimmunotherapy-pit-phase-2-study-results-30-patients-with-a-43-orr-amp-os-of-9-2-months-phase-3-study-is-being-fast-tracked/10006308
[4] https://mocbrasil.com/blog/asco-2019/asco-2019-dr-felipe-moraes-updates-em-cancer-de-rim-e-cancer-de-bexiga/?platform=hootsuite

Top URLs in Tweet in G3:
[9] https://www.smashwords.com/books/view/936688?platform=hootsuite
[6] https://ascopubs.org/doi/full/10.1200/EDBK_100019
[6] https://www.adcreview.com/conference-coverage/asco-2019-adc-presentation-guide/
[6] https://oncozine.com/findings-from-two-tapur-study-cohorts-to-be-presented-at-2019-annual-asco-meeting/
[6] https://www.ajmc.com/newsroom/5-takeaways-from-ascos-annual-meeting
[6] https://www.oncologyeducation.com/events/upcoming-events/
[5] https://www.adcreview.com/conference-coverage/new-data-demonstrates-potential-for-remegens-rc48-in-her2-cancers/
[5] https://oncozine.com/category/conference-coverage/
[5] https://www.statnews.com/2019/06/02/the-affordable-care-act-erased-a-racial-disparity-in-cancer-care-a-new-study-says/
[4] https://dailynews.ascopubs.org/do/10.1200/ADN.19.190315/full/

Top URLs in Tweet in G4:
[3] http://lilly.com/who-we-are/business-areas/oncology/curevac-collaboration-update
[3] https://go.ccalliance.org/2018yosrs
[3] https://www.fiercebiotech.com/biotech/asco-amgen-s-kras-drug-first-to-clinic-shrinks-nsclc-curbs-colorectal-tumors?fbclid=IwAR0aizkH-VGUt87iXs5TVPWJu-1uyAQ5S9MJkfB3wa5NtrgZ_hrFzHCcuzM
[2] https://consultqd.clevelandclinic.org/could-immunotherapy-help-cure-cutaneous-squamous-cell-carcinoma/?utm_campaign=qd%20tweets&utm_medium=social&utm_source=twitter&utm_content=060319%20ASCO&cvosrc=social%20network.twitter.qd%20tweets&cvo_creative=060319%20ASCO
[2] https://consultqd.clevelandclinic.org/rivaroxaban-reduces-vte-in-patients-with-pancreatic-cancer/?utm_campaign=qd%20tweets&utm_medium=social&utm_source=twitter&utm_content=060319%20ASCO&cvosrc=social%20network.twitter.qd%20tweets&cvo_creative=060319%20ASCO
[2] https://consultqd.clevelandclinic.org/new-renal-cancer-therapy-effective-in-higher-risk-groups/?utm_campaign=qd%20tweets&utm_medium=social&utm_source=twitter&utm_content=190603%20renal%20risk&cvosrc=social%20network.twitter.qd%20tweets&cvo_creative=190603%20renal%20risk
[2] https://www.ascopost.com/videos/2019-asco-annual-meeting/manmeet-ahluwalia-on-glioblastoma-novel-cancer-vaccine-with-standard-therapy/
[2] https://www.healio.com/hematology-oncology/practice-management/news/online/{20a655db-f484-4534-b782-464e438ca49e}/speaker-introductions-at-major-meetings-may-strengthen-gender-bias
[2] https://www.healio.com/hematology-oncology/myeloma/news/online/{2074c440-3f93-49ce-9859-b65eaee3a3ae}/isatuximab-regimen-extends-pfs-in-relapsed-refractory-multiple-myeloma
[2] http://trialfinder.fightcrc.org

Top URLs in Tweet in G5:
[20] https://seom.org/formacion/formacion-on-line/onconexion-2019
[19] https://elpais.com/elpais/2019/06/06/ciencia/1559836593_115131.html
[16] https://www.nejm.org/doi/full/10.1056/NEJMoa1903765
[10] https://www.efesalud.com/asco-2019-cumbre-oncologia-diez-claves/
[9] https://www.nejm.org/doi/full/10.1056/NEJMoa1903835
[6] https://www.elglobal.es/industria-farmaceutica/asco-2019-asienta-los-cimientos-de-la-revolucion-en-inmunoterapia-NY2111483
[6] https://lungcancerupdates.es/asco2019/#lo-mejor-de
[5] https://www.nejm.org/doi/full/10.1056/NEJMe1906088
[5] https://www.nejm.org/doi/full/10.1056/NEJMoa1903387
[5] http://www.abbvie.com/onc-jobs

Top URLs in Tweet in G6:
[15] https://www.sciencesetavenir.fr/sante/cancer/asco-2019-des-nanoparticules-testees-dans-les-cancers-orl_134164?utm_medium=Social&utm_source=Twitter#Echobox=1559667159
[7] https://news.bms.com/press-release/corporatefinancial-news/five-year-survival-observed-longest-follow-date-advanced-melan?linkId=68493950
[5] https://www.lequotidiendupharmacien.fr/actualite-pharmaceutique/article/2019/06/04/le-cannabis-therapeutique-nuirait-lefficacite-des-chimiotherapies_278613
[5] https://lecancer.fr/congres/congres-americain-cancerologie-2019-pharma/3-juin/resultats-finaux-updates-de-letude-columbus-confirment-lefficacite-de-combinaison-encorafenib-binimetinib-melanome-metastatique-braf-mute/
[4] https://lecancer.fr/congres/congres-americain-cancerologie-2019-pharma/3-juin/melanome-dantibiotiques-anti-pd1/
[4] https://lecancer.fr/congres/congres-americain-cancerologie-2019-pharma/4-juin/neratinib-resultats-positifs-cancer-sein-her2-positif-metastatique/
[4] https://www.canceradvocacy.org/cancer-advocacy/survivor-stories/
[3] https://lecancer.fr/congres/congres-americain-cancerologie-2019-pharma/4-juin/capivasertib-inhibiteur-akt-associe-fulvestrant/
[3] https://lecancer.fr/congres/congres-americain-cancerologie-2019-pharma/3-juin/asco-2019-traiter-chacun-patients-apprendre-de-chacun-patients/
[3] https://lecancer.fr/congres/congres-americain-cancerologie-2019-pharma/3-juin/femmes-viennent-de-venus-subissent-plus-deffets-indesirables-hommes/

Top URLs in Tweet in G7:
[9] https://www.evaluate.com/vantage/articles/events/conferences/asco-2019-event-analyser-low-key-meeting-belies-some-huge-stock
[4] https://twitter.com/Plenary_Session/status/1135965263357079552
[4] https://www.statnews.com/2019/06/03/at-asco-targeted-lung-cancer-drugs-shrink-tumors-caused-by-rare-genetic-mutations/
[3] https://www.statnews.com/2019/06/04/what-you-missed-at-asco-a-lot-as-cancer-research-hastens-on/
[3] https://www.evaluate.com/vantage/articles/events/conferences/asco-2019-macrogenics-builds-case-margetuximab
[2] https://www.mdmag.com/conference-coverage/asco-2019/low-income-female-patients-delayed-leukemia-diagnoses
[2] https://www.blueprintmedicines.com/wp-content/uploads/2019/05/Blueprint-Medicines-ASCO-2019-BLU-667-NSCLC-Presentation.pdf
[2] http://ir.blueprintmedicines.com/events/event-details/blueprint-medicines-asco-2019-analyst-and-investor-reception
[2] https://www.statnews.com/2019/06/04/podcast-asco-2019-recap/
[2] https://www.statnews.com/2019/06/03/at-asco-targeted-lung-cancer-drugs-shrink-tumors-caused-by-rare-genetic-mutations?utm_content=buffer03ccb&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic

Top URLs in Tweet in G8:
[9] http://po.st/Pwb5WW
[4] https://twitter.com/ICR_London/status/1136645099356639232
[4] http://po.st/SzssYW
[3] https://www.telegraph.co.uk/news/2019/06/04/drug-helps-woman-survive-breast-cancer-can-also-stop-prostate/
[2] https://twitter.com/Maherjane/status/1134887217921437696
[2] https://twitter.com/ASCO/status/1135969545548652545
[2] https://twitter.com/wisserleben/status/1135570227968860161
[2] https://clinicaltrials.gov/ct2/show/NCT02358031
[2] https://www.thetimes.co.uk/article/simple-blood-test-can-pinpoint-if-cancer-will-return-d3xnxpfcr
[2] https://oncologynursinginpractice.com/

Top URLs in Tweet in G9:
[10] https://www.fiercebiotech.com/biotech/asco-fda-review-nearing-epizyme-shares-updated-sarcoma-data?utm_source=internal&utm_medium=rss
[5] https://www.biospace.com/article/thrive-early-detection-launches-out-of-johns-hopkins-with-110-million-series-a/
[3] https://www.trustacrossamerica.com/tap-into-trust.shtml
[2] https://twitter.com/itsnot_pink/status/1134997499029151744
[2] https://twitter.com/ASCO/status/1135969545548652545
[2] https://healthbook.ch/login-page/?r=http://healthbook.ch/oncology-hematology/news/asco-2019-newsroom/
[2] http://www.merck.com/about/featured-stories/building-a-strong-foundation-in-pancreatic-cancer-research.html
[1] https://twitter.com/ACLU/status/1135595602711064576
[1] https://twitter.com/ModernMedEd/status/1135622985262534657
[1] http://www.viracta.com/pressreleases/June32019.html

Top URLs in Tweet in G10:
[3] https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(19)30103-6/fulltext
[3] https://www.docwirenews.com/docwire-pick/future-of-medicine-picks/veracytes-genomic-test-could-greatly-improve-thyroid-cancer-management/?utm_source=twittershare&utm_medium=socialmedia&utm_campaign=social_media_track
[2] https://www.nejm.org/doi/full/10.1056/NEJMoa1903765
[2] https://twitter.com/VanAllenLab/status/1135617411464552450
[2] http://onco-actu.e-cancer.fr/2019/06/onco-actu-du-4-juin-2019-special-asco.html
[1] https://www.nature.com/articles/d41573-019-00090-z
[1] https://www.nature.com/articles/s41571-019-0222-4
[1] https://www.nature.com/articles/s41591-018-0053-3
[1] https://www.onconews.com.br/site/coberturasespeciais/coberturasespeciais/asco-2019/4219-neuro-onco,-o-que-h%C3%A1-de-novo.html
[1] https://www.onconews.com.br/site/coberturasespeciais/coberturasespeciais/asco-2019/4208-anticorpo-conjugado-%C3%A9-nova-promessa-no-c%C3%A2ncer-urotelial.html

Top Domains
Top Domains in Tweet in Entire Graph:
[1062] twitter.com
[217] asco.org
[174] ascopubs.org
[133] medscape.com
[117] ascopost.com
[106] onclive.com
[96] nejm.org
[69] urotoday.com
[67] oncologytube.com
[61] symplur.com

Top Domains in Tweet in G1:
[564] twitter.com
[88] ascopost.com
[85] onclive.com
[68] asco.org
[64] ascopubs.org
[48] symplur.com
[42] targetedonc.com
[38] vjhemonc.com
[37] medpagetoday.com
[25] oncoinfo.it

Top Domains in Tweet in G2:
[150] twitter.com
[68] urotoday.com
[61] oncologytube.com
[56] medscape.com
[41] mocbrasil.com
[41] 1stoncology.com
[36] asco.org
[33] obroncology.com
[26] vjoncology.com
[20] nejm.org

Top Domains in Tweet in G3:
[114] twitter.com
[64] ascopubs.org
[28] oncologyeducation.com
[22] adcreview.com
[21] ajmc.com
[20] oncology-central.com
[20] oncozine.com
[17] asco.org
[14] medidact.com
[10] medicinematters.com

Top Domains in Tweet in G4:
[22] twitter.com
[10] clevelandclinic.org
[8] healio.com
[6] lilly.com
[5] gene.com
[4] fiercebiotech.com
[4] survivornet.com
[4] dy.si
[3] ascopost.com
[3] medscape.com

Top Domains in Tweet in G5:
[49] nejm.org
[36] twitter.com
[21] seom.org
[20] elpais.com
[18] pharmaphorum.com
[10] efesalud.com
[9] abbvie.com
[9] immedicohospitalario.es
[7] asco.org
[7] lungcancerupdates.es

Top Domains in Tweet in G6:
[34] lecancer.fr
[19] sciencesetavenir.fr
[12] twitter.com
[12] biocentury.com
[11] bms.com
[6] francetvinfo.fr
[6] gustaveroussy.fr
[5] leparisien.fr
[5] lequotidiendupharmacien.fr
[5] canceradvocacy.org

Top Domains in Tweet in G7:
[28] twitter.com
[26] statnews.com
[20] evaluate.com
[14] asco.org
[8] youtube.com
[7] aphp.fr
[6] onclive.com
[5] fiercebiotech.com
[5] cnbc.com
[4] blueprintmedicines.com

Top Domains in Tweet in G8:
[21] twitter.com
[15] po.st
[9] cancerhealth.com
[8] ac.uk
[7] co.uk
[4] oncologynursinginpractice.com
[3] theguardian.com
[2] nejm.org
[2] ascopubs.org
[2] cancerresearchuk.org

Top Domains in Tweet in G9:
[24] twitter.com
[13] fiercebiotech.com
[7] instagram.com
[7] lnkd.in
[7] medscape.com
[6] biospace.com
[5] onclive.com
[5] asco.org
[5] healthbook.ch
[5] saluteh24.com

Top Domains in Tweet in G10:
[24] com.br
[9] docwirenews.com
[8] twitter.com
[6] thelancet.com
[3] nature.com
[2] nejm.org
[2] e-cancer.fr
[1] youtube.com
[1] medium.com
[1] ascopubs.org

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[13749] asco19
[612] cancer
[608] lcsm
[543] bcsm
[468] breastcancer
[364] oncoalert
[326] oncology
[312] lymsm
[312] asco2019
[270] immunotherapy



Top Hashtags in Tweet in G1:
[5877] asco19
[435] lcsm
[402] bcsm
[293] lymsm
[279] oncoalert
[205] leusm
[178] breastcancer
[176] gerionc
[141] gyncsm
[118] mmsm

Top Hashtags in Tweet in G2:
[1783] asco19
[80] mocnaasco
[73] prostatecancer
[70] enzamet
[69] breastcancer
[66] immunotherapy
[56] kidneycancer
[50] bladdercancer
[40] lcsm
[40] cancer

Top Hashtags in Tweet in G3:
[1451] asco19
[74] breastcancer
[71] lcsm
[65] cancer
[63] brca
[50] bcsm
[48] oncology
[48] oncoalert
[45] ascodailynews
[44] asco2019

Top Hashtags in Tweet in G4:
[610] asco19
[64] cancer
[44] eliminatecancer
[34] colorectalcancer
[29] kidneycancer
[23] eha24
[23] lcsm
[19] oncology
[16] lungcancer
[13] leukemia

Top Hashtags in Tweet in G5:
[686] asco19
[36] cholangiocarcinoma
[35] ovariancancer
[34] ascolci
[31] btsm
[26] breastcancer
[26] oncology
[24] cáncer
[21] onconexion
[21] oncotype

Top Hashtags in Tweet in G6:
[446] asco19
[44] cancer
[40] asco2019
[20] cancers
[15] mélanome
[13] immunothérapie
[13] melanoma
[13] pancreaticcancer
[11] cancerdusein
[11] patients

Top Hashtags in Tweet in G7:
[460] asco19
[25] cancer
[11] trialsjournal
[10] biotech
[9] pancreaticcancer
[9] immunotherapy
[8] oncology
[7] survivors
[7] healthcare
[6] disparities

Top Hashtags in Tweet in G8:
[255] asco19
[23] cancer
[21] breastcancer
[20] prostatecancer
[13] immunotherapy
[7] lungcancer
[7] oncologynursinginpractice
[6] elearning
[4] oncology
[3] headandneckcancer

Top Hashtags in Tweet in G9:
[222] asco19
[13] asco
[12] cancer
[12] asco2019
[10] oncology
[7] chicago
[6] asc02019
[6] pancreaticcancer
[5] pharma
[4] trust

Top Hashtags in Tweet in G10:
[201] asco19
[31] immunotherapy
[28] asco2019
[25] asco
[25] onconewsnoasco19
[24] onconews
[13] gerituzumab
[9] sarcoma
[4] genomics
[4] thyroidcancer

Top Words
Top Words in Tweet in Entire Graph:
[16942] Words in Sentiment List#1: Positive
[8994] Words in Sentiment List#2: Negative
[44] Words in Sentiment List#3: Angry/Violent
[412842] Non-categorized Words
[438778] Total Words
[13694] #asco19
[3120] cancer
[2851] asco
[2410] patients
[2221] dr

Top Words in Tweet in G1:
[5873] #asco19
[1215] asco
[1155] dr
[935] patients
[921] cancer
[580] trial
[550] s
[513] great
[498] study
[467] data

Top Words in Tweet in G2:
[1782] #asco19
[474] cancer
[443] asco
[373] dr
[329] s
[327] patients
[319] study
[293] trial
[250] therapy
[228] data

Top Words in Tweet in G3:
[1449] #asco19
[614] asco
[409] cancer
[258] dr
[186] patients
[185] s
[178] more
[139] data
[125] trial
[118] great

Top Words in Tweet in G4:
[610] #asco19
[277] patients
[246] cancer
[240] new
[222] cleclinicmd
[146] learn
[142] more
[135] therapy
[129] study
[122] cell

Top Words in Tweet in G5:
[686] #asco19
[177] nejm
[144] asco
[134] _seom
[117] trial
[107] patients
[93] dr
[88] therapy
[87] sobre
[81] cancer

Top Words in Tweet in G6:
[416] #asco19
[179] des
[138] les
[132] à
[127] gustaveroussy
[107] cancer
[99] institut_curie
[95] dans
[92] l
[81] asco

Top Words in Tweet in G7:
[450] #asco19
[141] cancer
[80] patients
[79] kras
[60] data
[60] l
[52] s
[49] new
[48] trial
[47] dr

Top Words in Tweet in G8:
[255] #asco19
[165] cancer
[99] trial
[82] new
[69] icr_london
[59] patients
[58] cr_uk
[55] news
[55] drug
[49] results

Top Words in Tweet in G9:
[222] #asco19
[39] asco
[32] cancer
[26] patients
[24] data
[17] oncology
[17] more
[14] time
[14] chicago
[14] clinical

Top Words in Tweet in G10:
[200] #asco19
[50] cancer
[49] asco
[47] session
[43] clinical
[40] immunotherapy
[38] vanallenlab
[34] educational
[34] siwenonc
[34] drake

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[472] breast,cancer
[440] presented,#asco19
[397] asco,#asco19
[309] learn,more
[294] lung,cancer
[276] #asco19,#lcsm
[261] targeted,therapy
[243] cancer,patients
[234] asco,2019
[230] #asco19,asco

Top Word Pairs in Tweet in G1:
[222] breast,cancer
[204] #asco19,#lcsm
[173] asco,#asco19
[147] lung,cancer
[140] #asco19,#lymsm
[140] 9,45
[136] #lymsm,#leusm
[132] 6,4
[131] tues,6
[130] 4,19

Top Word Pairs in Tweet in G2:
[149] m,d
[141] study,found
[141] targeted,therapy
[138] marwan,fakih
[136] cityofhope,city
[136] city,hope
[136] hope,s
[136] s,marwan
[136] fakih,m
[136] d,served

Top Word Pairs in Tweet in G3:
[64] asco,#asco19
[57] financial,impact
[57] breast,cancer
[55] more,americans
[55] americans,worried
[55] worried,cancer
[55] cancer,s
[55] s,financial
[55] impact,dying
[55] dying,cancer

Top Word Pairs in Tweet in G4:
[121] learn,more
[96] cell,carcinoma
[88] cleclinicmd,new
[68] curative,potential
[68] potential,immunotherapy
[68] immunotherapy,patients
[64] squamous,cell
[62] cutaneous,squamous
[61] patients,cutaneous
[60] study,evaluate

Top Word Pairs in Tweet in G5:
[74] _seom,#asco19
[54] monaleesa,7
[44] vídeo,resumen
[42] original,article
[40] #asco19,quieres
[38] quieres,conocer
[36] nejm,original
[32] endocrine,therapy
[32] #ovariancancer,remains
[32] remains,one

Top Word Pairs in Tweet in G6:
[42] asco,2019
[40] sylvie,bonvalot
[33] dr,sylvie
[31] gustaveroussy,#asco19
[30] bonvalot,led
[30] led,exceptional
[30] exceptional,global
[30] global,study
[30] study,treating
[30] treating,type

Top Word Pairs in Tweet in G7:
[26] cancer,patients
[26] lung,cancer
[23] kras,g12c
[22] drug,hunters
[22] hunters,finally
[22] finally,cracked
[22] cracked,kras
[22] kras,basic
[22] basic,science
[22] science,research

Top Word Pairs in Tweet in G8:
[36] clinical,trial
[34] prostate,cancer
[31] pancreatic,cancer
[27] cancer,#asco19
[27] cancer,patients
[26] presented,#asco19
[23] breast,cancer
[23] trial,results
[23] icr,royalmarsdennhs
[23] start,new

Top Word Pairs in Tweet in G9:
[11] #asco19,#asco2019
[10] #asco,#asco19
[10] asco,fda
[10] fda,review
[10] review,nearing
[10] nearing,epizyme
[10] epizyme,shares
[10] shares,updated
[10] updated,sarcoma
[10] sarcoma,data

Top Word Pairs in Tweet in G10:
[36] cancer,immunotherapy
[34] immunotherapy,#asco19
[34] #asco19,educational
[34] educational,session
[33] talking,clinical
[33] clinical,genomics
[33] genomics,cancer
[33] session,siwenonc
[33] siwenonc,chuck
[33] chuck,drake

Top Replied-To
Top Replied-To in Entire Graph:
@marklewismd
@asco
@symplur
@tmprowell
@narjustdumamd
@stage4kelly
@itsnot_pink
@stales
@corrie_painter
@ashleysumrallmd

Top Replied-To in G1:
@marklewismd
@symplur
@narjustdumamd
@tmprowell
@itsnot_pink
@stales
@stage4kelly
@erikahamilton9
@corrie_painter
@yzafar

Top Replied-To in G2:
@asco
@fabioschutz78
@bbhindi
@neerajaiims
@pgrivasmdphd
@therealjasonzhu
@tmprowell
@drsgraff
@nektar
@uccancercenter

Top Replied-To in G3:
@asco
@crisbergerot
@evettus
@ashleysumrallmd
@johntuckerphd
@cancerassassin1
@fogaccijoao
@tgeorgemd
@radonc_ai
@bogda_koczwara

Top Replied-To in G4:
@eileenkois
@brendonstilesmd
@drmalikasiker
@fightcrc
@ccalliance
@jesscatlin
@w2ogroup
@health_journo
@smitha42

Top Replied-To in G5:
@hemoncwomendocs
@lifeiskitsch
@jmsepulveda01
@stage4kelly
@bidencancer

Top Replied-To in G6:
@bmsnews
@dolesmarlon

Top Replied-To in G7:
@genoceabio
@marklewismd
@garridolagunamd
@dzalkowitz
@vprasadmdmph
@barrosonco
@_superbrat_
@jacobplieth
@adamfeuerstein

Top Replied-To in G10:
@ckadoch
@thelancetoncol
@vincentrk
@conquercancerfd
@vanallenlab

Top Mentioned
Top Mentioned in Entire Graph:
@asco
@narjustdumamd
@tmprowell
@drsgraff
@marklewismd
@nejm
@cleclinicmd
@stage4kelly
@cityofhope
@matteolambe

Top Mentioned in G1:
@asco
@narjustdumamd
@tmprowell
@drsgraff
@marklewismd
@stage4kelly
@oncoalert
@mdandersonnews
@sloan_kettering
@symplur

Top Mentioned in G2:
@asco
@cityofhope
@neerajaiims
@montypal
@medscapeonc
@mocbrasil
@fabioschutz78
@drchoueiri
@thenci
@urotoday

Top Mentioned in G3:
@asco
@matteolambe
@fumikochino
@aacr
@elisabethmking
@adcreview
@amanchauhanmd
@tmprowell
@ukmarkey
@cphiww

Top Mentioned in G4:
@cleclinicmd
@genentech
@novartiscancer
@janssenus
@fightcrc
@lillypad
@exelixisinc
@amgen
@takedaoncology
@novartis

Top Mentioned in G5:
@nejm
@_seom
@gedefo_sefh
@asco
@merck
@vhio
@ashleysumrallmd
@el_pais
@kantar_health
@cca_alliance

Top Mentioned in G6:
@institut_curie
@gustaveroussy
@asco
@astrazeneca
@msdfroncologie
@gilles_vassal
@davisa20
@mattyurgelun
@lecancerfr
@sciences_avenir

Top Mentioned in G7:
@vprasadmdmph
@aphp
@adamfeuerstein
@ucsfcancer
@statnews
@innatepharma
@kevansf
@asco
@bayareabiotechi
@matthewherper

Top Mentioned in G8:
@icr_london
@cr_uk
@royalmarsdennhs
@sarahhalford7
@breastcancernow
@asco
@telegraph
@guardian
@crukresearch
@scienceofsarah

Top Mentioned in G9:
@stcks4
@ce3inc
@barbarakimmel

Top Mentioned in G10:
@vanallenlab
@siwenonc
@asco
@col
@jsoriamd
@natrevclinoncol
@thelancet
@oncogeri
@mydocwire
@school_latin

Top Tweeters
Top Tweeters in Entire Graph:
@lopezgovlaw
@united
@delta
@llemj
@chidambara09
@repubblica
@netminnow
@guardian
@el_pais
@lavanguardia

Top Tweeters in G1:
@netminnow
@mobilepunch
@natricer
@letat_lechat
@abcdiagnosis
@airbnbhelp
@caring_mobile
@ajc
@jessicafastball
@cbsnews

Top Tweeters in G2:
@lopezgovlaw
@united
@delta
@bmlewis2
@dsirmtcom
@washingtonpost
@pash22
@janattheocean
@straitarrow10
@gladeolie

Top Tweeters in G3:
@chidambara09
@repubblica
@threadreaderapp
@marclandes40
@wsj
@emmabbooks
@ap
@theshex
@primocanale
@kfnx_headlines

Top Tweeters in G4:
@kingsfanone
@bostonherald
@hellahandbasket
@rich_893
@truth_tweeters
@queenmsheba
@myglobalpac
@no2l
@gloriaminott
@awsom_1

Top Tweeters in G5:
@el_pais
@lavanguardia
@elperiodico
@catinformacio
@jerusalem_post
@mariuskarma
@monitor_ph
@catalunyaradio
@culturalhistory
@56mimihoward

Top Tweeters in G6:
@cybermanin
@lesechos
@europe1
@le_parisien
@evymoyenin
@jackleslwt
@cd_land
@franceinfo
@heatherswifty
@libe

Top Tweeters in G7:
@bioportfolio
@lemondefr
@cnbc
@akdm_bot
@drkynast
@donnayoungdc
@portefeuillefun
@iamukasa
@matthewherper
@seasolicitorcjs

Top Tweeters in G8:
@guardian
@telegraph
@metrouk
@thetimes
@beautifulmumsie
@deadblurryface
@cr_uk
@breastcancernow
@riddler_smitb
@1stdarwin

Top Tweeters in G9:
@sesiegler
@cmiller1225
@barbarakimmel
@healthierit
@contentcarnivor
@nevitdilmen
@markpow1
@giovannyleon
@drcherylllp
@zackcapp

Top Tweeters in G10:
@bostonnews002
@dnaed_tech
@kj_hashi
@sakditouch128
@marianelacastes
@eowalong
@johnran28545123
@mathcancer
@ara_anderson
@jczm1991


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.